# DESCRIPTION

## TECHNICAL FIELD

- define technical field of invention

## BACKGROUND

- describe limitations of current treatments

## SUMMARY

- summarize nucleic acid molecule encoding DMAb
- summarize nucleic acid molecule encoding cleavage domain
- summarize composition comprising nucleic acid molecule
- summarize method of preventing/treating disease/biofilm formation

## DETAILED DESCRIPTION

- describe composition and synthetic antibody

### 1. DEFINITIONS

- define technical terms
- introduce open-ended transitional phrases
- define antibody and its fragments
- define antigen and coding sequence
- define complement, constant current, and feedback
- define electroporation, endogenous antibody, and genetic construct
- define immune response
- define nucleic acid
- define operably linked
- define promoter
- define signal peptide
- define other terms

### 2. COMPOSITION

- define recombinant nucleic acid sequence
- describe composition embodiments
- specify nucleotide sequences for antibodies
- outline RNA molecule embodiments
- describe therapeutic applications
- describe composition
- describe bispecific antibodies
- define tumor associated surface antigen
- list tumor associated surface antigens
- describe T-cell specific receptor molecules
- describe bispecific antibody embodiments
- define recombinant nucleic acid sequence
- describe recombinant nucleic acid sequence construct
- detail components of recombinant nucleic acid sequence construct
- specify promoters and enhancers
- describe recombinant nucleic acid sequence construct
- detail components of construct
- describe arrangement of components
- outline expression from construct
- describe vector
- detail types of vectors
- describe expression vector
- describe plasmid
- describe RNA vectors
- describe circular and linear vectors
- describe viral vectors and method of preparing vector

### 3. ANTIBODY

- define antibody structure
- describe antibody types
- discuss antibody modifications
- describe bispecific and bifunctional antibodies

### 4. ANTIGEN

- define antigen types
- describe bacterial antigens

### 5. EXCIPIENTS AND OTHER COMPONENTS OF THE COMPOSITION

- describe pharmaceutically acceptable excipients
- discuss transfection facilitating agents

### 6. METHOD OF GENERATING THE SYNTHETIC ANTIBODY

- describe method of generating synthetic antibody

### 7. METHOD OF IDENTIFYING OR SCREENING FOR THE ANTIBODY

- describe method of identifying or screening for antibody

### 8. METHOD OF DELIVERY OF THE COMPOSITION

- describe administration methods
- specify delivery routes
- detail electroporation administration
- reference prior art electroporation devices

### 9. METHOD OF TREATMENT

- provide method of treating disease
- administer composition to subject
- generate synthetic antibody in subject
- bind to or react with antigen
- treat, protect against, and/or prevent disease
- specify composition dose and administration
- provide non-limiting examples of antibiotics
- describe Western Blot method
- describe mice model preparation
- describe lethal pneumonia challenge
- describe histopathology analysis
- describe statistics analysis
- describe design and in vitro expression of anti-P. aeruginosa DMAbs
- describe expression of anti-P. aeruginosa DMAbs in mice
- evaluate DMAb-Î±PcrV and DMAb-BiSPA in a lethal pneumonia model
- describe lung histopathology following challenge
- discuss DMAb combination with antibiotics and future applications

